Your browser doesn't support javascript.
loading
Structure-Activity Relationship of Truncated 2,8-Disubstituted-Adenosine Derivatives as Dual A2A/A3 Adenosine Receptor Antagonists and Their Cancer Immunotherapeutic Activity.
Kim, Gibae; Hou, Xiyan; Byun, Woong Sub; Kim, Gyudong; Jarhad, Dnyandev B; Lee, Grim; Hyun, Young Eum; Yu, Jinha; Lee, Chang Soo; Qu, Shuhao; Warnick, Eugene; Gao, Zhan-Guo; Kim, Ji Yong; Ji, Seunghee; Shin, Hyunwoo; Choi, Jong-Ryoul; Jacobson, Kenneth A; Lee, Hyuk Woo; Lee, Sang Kook; Jeong, Lak Shin.
Afiliación
  • Kim G; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Hou X; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Byun WS; College of Life Science, Dalian Minzu University, Dalian 116600, People's Republic of China.
  • Kim G; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Jarhad DB; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, California 94305, United States.
  • Lee G; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Hyun YE; College of Pharmacy & Research Institute of Drug Development, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Yu J; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Lee CS; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Qu S; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Warnick E; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Gao ZG; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea.
  • Kim JY; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Ji S; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Shin H; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892, United States.
  • Choi JR; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892, United States.
  • Jacobson KA; Future Medicine Company Limited, Seoul 06665, Republic of Korea.
  • Lee HW; HK Inno.N Corporation, Seoul 04551, Republic of Korea.
  • Lee SK; HK Inno.N Corporation, Seoul 04551, Republic of Korea.
  • Jeong LS; HK Inno.N Corporation, Seoul 04551, Republic of Korea.
J Med Chem ; 66(17): 12249-12265, 2023 09 14.
Article en En | MEDLINE | ID: mdl-37603705
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenosina / Neoplasias Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenosina / Neoplasias Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article